ECSP044948A - COMBINATIONS THAT INCLUDE EPOTILONES AND THEIR PHARMACEUTICAL USES - Google Patents
COMBINATIONS THAT INCLUDE EPOTILONES AND THEIR PHARMACEUTICAL USESInfo
- Publication number
- ECSP044948A ECSP044948A ECSP044948A ECSP044948A EC SP044948 A ECSP044948 A EC SP044948A EC SP044948 A ECSP044948 A EC SP044948A EC SP044948 A ECSP044948 A EC SP044948A
- Authority
- EC
- Ecuador
- Prior art keywords
- treatment
- epotilones
- combinations
- progression
- delay
- Prior art date
Links
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 230000002062 proliferating effect Effects 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
en donde A representa O u NRN, en donde RN es hidrógeno o alquilo inferior, R es hidrógeno o alquilo inferior, y Z es O, o un enlace, en donde los ingredientes activos (a) y (b) están presentes en cada caso en forma libre o en la forma de una sal farmacéuticamente aceptable y opcionalmente por lo menos un vehículo farmacéuticamente aceptable para el uso simultáneo, separado o secuencial, en particular para el retraso de la progresión o para el tratamiento de una enfermedad proliferativa, especialmente una enfermedad de tumor sólido; una composición farmacéutica, un paquete comercial o un producto que comprende dicha combinación; el uso de dicha combinación para la preparación de un medicamento para el retraso de la progresión o para el tratamiento de una enfermedad proliferativa y a un método para el tratamiento de un animal de sangre caliente.wherein A represents O or NRN, where RN is hydrogen or lower alkyl, R is hydrogen or lower alkyl, and Z is O, or a bond, wherein the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the delay of progression or for the treatment of a proliferative disease, especially a disease solid tumor; a pharmaceutical composition, a commercial package or a product comprising said combination; the use of said combination for the preparation of a medicament for the delay of the progression or for the treatment of a proliferative disease and for a method for the treatment of a warm-blooded animal.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30657101P | 2001-07-19 | 2001-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP044948A true ECSP044948A (en) | 2004-02-26 |
Family
ID=33449495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP044948 ECSP044948A (en) | 2001-07-19 | 2004-01-16 | COMBINATIONS THAT INCLUDE EPOTILONES AND THEIR PHARMACEUTICAL USES |
Country Status (2)
| Country | Link |
|---|---|
| EC (1) | ECSP044948A (en) |
| ZA (1) | ZA200309898B (en) |
-
2003
- 2003-12-22 ZA ZA200309898A patent/ZA200309898B/en unknown
-
2004
- 2004-01-16 EC ECSP044948 patent/ECSP044948A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200309898B (en) | 2004-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP094948A (en) | COMBINATIONS THAT INCLUDE EPOTILONES AND THEIR PHARMACEUTICAL USES | |
| AR028504A2 (en) | COMBINATION, METHOD FOR IMPROVING THE BODY APPEARANCE OF A MAMMER, PHARMACEUTICAL COMPOSITION, USE OF SUCH COMBINATION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTION, DELAY OF PROGRESS, OR TREATMENT OF METABOLIC DISORDERS, AND COMMERCIAL PACKAGE | |
| UY26372A1 (en) | "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM" | |
| AR048502A1 (en) | ANTI-CANCER COMPOUND THERAPEUTIC SYNERGY | |
| PT1093819E (en) | COMPOUNDS AND COMPOSITIONS FOR THE SUPPLY OF ACTIVE AGENTS | |
| BR0112311A (en) | Active agent release compounds and compositions, unit dosage form, method for preparing said compositions and their use | |
| EE05065B1 (en) | Urea substituted imidazoquinolines, their use in therapy and pharmaceutical preparations containing them | |
| AR044923A1 (en) | IMIDAZOQUINOLINAS REPLACED WITH SULFONAMIDE | |
| EA200501586A1 (en) | PHARMACEUTICAL PRODUCTS | |
| EE05074B1 (en) | Sulphonamide- and sulphamide-substituted imidazoquinolines, their use in therapy and pharmaceutical preparations containing them | |
| DK1036058T3 (en) | adamantane | |
| DE69808130D1 (en) | Adamantane derivatives | |
| SE9704546D0 (en) | Novel compounds | |
| ES2161085T3 (en) | FORMULATIONS CONTAINING OXALIPLATIN. | |
| ES2080307T3 (en) | PHARMACEUTICAL COMPOSITIONS. | |
| CL2009001899A1 (en) | Pharmaceutical composition comprising: i) an at1 receptor antagonist or a salt, ii) an insulin sensitizer or a salt and iii) a pharmaceutically acceptable carrier; use for the prevention, delay of progress or treatment of hypertension, diabetes, among others (div. sol. 2034-01). | |
| ES2042776T3 (en) | A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION. | |
| AR012125A1 (en) | A SALT OF A COMPOUND DERIVED FROM CARBOXYLLIC NAFTIRIDINE ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT | |
| ATE287264T1 (en) | ORAL MEDICINAL PRODUCTS CONTAINING BUPRENORPHINE | |
| ITMI921930A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF DIHYDROPYRIDINS IN THE FORM OF DRINK | |
| ES2163896T3 (en) | COMPOSITIONS TO INCREASE THE CONCENTRATION AND / OR MOTILITY OF SPERMATOZES IN HUMANS. | |
| IT8584151A0 (en) | PROCEDURE FOR THE SANITIZATION OF CONTAINERS AND PACKAGING MATERIALS, PARTICULARLY FOR PHARMACEUTICAL AND COSMETIC USE, AND SYSTEM TO CARRY OUT THE PROCEDURE. | |
| DE60333754D1 (en) | EPOTHILONE CONTAINING COMBINATIONS AND THEIR PHARMACEUTICAL USES | |
| AR011437A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT. | |
| ECSP044948A (en) | COMBINATIONS THAT INCLUDE EPOTILONES AND THEIR PHARMACEUTICAL USES |